Are There Any Promising RNA Markers Currently in Use?
Yes, several RNA markers have shown promise in clinical settings. For example:
- BRCA1/BRCA2 mRNA: These markers are used to identify hereditary breast and ovarian cancers. - miR-21: This miRNA is commonly overexpressed in various cancers, including colorectal and breast cancer, and is associated with poor prognosis. - HOTAIR lncRNA: This long non-coding RNA is linked to tumor progression and metastasis in several cancers, including breast and gastric cancer.